Literature DB >> 16902192

Silica-directed mast cell activation is enhanced by scavenger receptors.

Jared M Brown1, Emily J Swindle, Nataliya M Kushnir-Sukhov, Andrij Holian, Dean D Metcalfe.   

Abstract

Inhalation of crystalline silica results in pulmonary fibrosis and silicosis. It has been suggested that mast cells play a role in these conditions. How mast cells would influence pathology is unknown. We thus explored mast cell interactions with silica in vitro and in B6.Cg-kit(W-sh) mast cell-deficient mice. B6.Cg-kit(W-sh) mice did not develop inflammation or significant collagen deposition after instillation of silica, while C57Bl/6 wild-type mice did have these findings. Given this supporting evidence of a role for mast cells in the development of silicosis, we examined the ability of silica to activate mouse bone marrow-derived mast cells (BMMC), including degranulation (beta-hexosaminidase release); production of reactive oxygen species (ROS) and inflammatory mediators; and the effects of silica on Fc epsilon RI-dependent activation. Silica did not induce mast cell degranulation. However, TNF-alpha, IL-13, monocyte chemotactic protein-1, protease activity, and production of ROS were dose-dependently increased after silica exposure, and production was enhanced after Fc epsilon RI stimulation. This mast cell activation was inhibited by anti-inflammatory compounds. As silica mediates some effects in macrophages through scavenger receptors (SRs), we first determined that mast cells express scavenger receptors; then explored the involvement of SR-A and macrophage receptor with colleagenous structure (MARCO). Silica-induced ROS formation, apoptosis, and TNF-alpha production were reduced in BMMC obtained from SR-A, MARCO, and SR-A/MARCO knockout mice. These findings demonstrate that silica directs mast cell production of inflammatory mediators, in part through SRs, providing insight into critical events in the pathogenesis and potential therapeutic targets in silicosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902192      PMCID: PMC1899302          DOI: 10.1165/rcmb.2006-0197OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

1.  IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling.

Authors:  Zhou Zhu; Bing Ma; Tao Zheng; Robert J Homer; Chun Geun Lee; Israel F Charo; Paul Noble; Jack A Elias
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

Review 2.  IL-13 effector functions.

Authors:  Thomas A Wynn
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice.

Authors:  Gloria S Pryhuber; Heidie L Huyck; Raymond Baggs; Günter Oberdörster; Jacob N Finkelstein
Journal:  Toxicol Sci       Date:  2003-03       Impact factor: 4.849

4.  Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice.

Authors:  J M Brown; A J Archer; J C Pfau; A Holian
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

5.  Silica-induced caspase activation in mouse alveolar macrophages is dependent upon mitochondrial integrity and aspartic proteolysis.

Authors:  M Thibodeau; C Giardina; A K Hubbard
Journal:  Toxicol Sci       Date:  2003-07-11       Impact factor: 4.849

Review 6.  Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung.

Authors:  C Edward Rose; Sung-Sang J Sung; Shu Man Fu
Journal:  Microcirculation       Date:  2003-06       Impact factor: 2.628

Review 7.  Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis.

Authors:  Bice Fubini; Andrea Hubbard
Journal:  Free Radic Biol Med       Date:  2003-06-15       Impact factor: 7.376

8.  Apoptosis underlies immunopathogenic mechanisms in acute silicosis.

Authors:  Valeria M Borges; Marcela F Lopes; Haroldo Falcão; José Henrique Leite-Júnior; Patricia R M Rocco; Wendy F Davidson; Rafael Linden; Walter A Zin; George A DosReis
Journal:  Am J Respir Cell Mol Biol       Date:  2002-07       Impact factor: 6.914

Review 9.  Tryptase, a novel link between allergic inflammation and fibrosis.

Authors:  Francesca Levi-Schaffer; Adrian M Piliponsky
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

10.  Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

Authors:  C G Lee; R J Homer; Z Zhu; S Lanone; X Wang; V Koteliansky; J M Shipley; P Gotwals; P Noble; Q Chen; R M Senior; J A Elias
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  34 in total

1.  SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors.

Authors:  Annette Plüddemann; Subhankar Mukhopadhyay; Marko Sankala; Silvana Savino; Mariagrazia Pizza; Rino Rappuoli; Karl Tryggvason; Siamon Gordon
Journal:  J Innate Immun       Date:  2008-09-11       Impact factor: 7.349

2.  A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis.

Authors:  Pranita Katwa; Xiaojia Wang; Rakhee N Urankar; Ramakrishna Podila; Susana C Hilderbrand; Robert B Fick; Apparao M Rao; Pu Chun Ke; Christopher J Wingard; Jared M Brown
Journal:  Small       Date:  2012-07-06       Impact factor: 13.281

Review 3.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

4.  Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation.

Authors:  Christopher J Wingard; Dianne M Walters; Brook L Cathey; Susana C Hilderbrand; Pranita Katwa; Sijie Lin; Pu Chun Ke; Ramakrishna Podila; Apparao Rao; Robert M Lust; Jared M Brown
Journal:  Nanotoxicology       Date:  2010-11-03       Impact factor: 5.913

5.  Implications of scavenger receptors in the safe development of nanotherapeutics.

Authors:  Jonathan H Shannahan; Wei Bai; Jared M Brown
Journal:  Receptors Clin Investig       Date:  2015

6.  Fibroblast growth on micro- and nanopatterned surfaces prepared by a novel sol-gel phase separation method.

Authors:  Paula Reemann; Triin Kangur; Martin Pook; Madis Paalo; Liis Nurmis; Ilmar Kink; Orm Porosaar; Külli Kingo; Eero Vasar; Sulev Kõks; Viljar Jaks; Martin Järvekülg
Journal:  J Mater Sci Mater Med       Date:  2012-12-13       Impact factor: 3.896

7.  Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.

Authors:  Abdullah A Aldossari; Jonathan H Shannahan; Ramakrishna Podila; Jared M Brown
Journal:  Toxicol In Vitro       Date:  2015-02       Impact factor: 3.500

8.  CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice.

Authors:  Fangwei Liu; Jie Liu; Dong Weng; Ying Chen; Laiyu Song; Qincheng He; Jie Chen
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

9.  Major vault protein regulates class A scavenger receptor-mediated tumor necrosis factor-α synthesis and apoptosis in macrophages.

Authors:  Jingjing Ben; Yan Zhang; Rongmei Zhou; Haiyang Zhang; Xudong Zhu; Xiaoyu Li; Hanwen Zhang; Nan Li; Xiaodan Zhou; Hui Bai; Qing Yang; Donghai Li; Yong Xu; Qi Chen
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

10.  Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation.

Authors:  Bettina M Jensen; Michael A Beaven; Shoko Iwaki; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Pharmacol Exp Ther       Date:  2007-10-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.